BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy3135
(229 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1W66|A Chain A, Structure Of A Lipoate-protein Ligase B From Mycobacterium
Tuberculosis
Length = 232
Score = 128 bits (322), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 78/200 (39%), Positives = 107/200 (53%), Gaps = 21/200 (10%)
Query: 5 VQLVRLGLVSYSNGIKIQEHYVNKLKTLISKPSNHSGTLLLLEHKPVYTIGIRSLKEYDE 64
+ + +LG V Y ++Q + ++ + + TLLLLEH VYT G R+ E
Sbjct: 14 IDVRQLGTVDYRTAWQLQRELAD------ARVAGGADTLLLLEHPAVYTAGRRT-----E 62
Query: 65 NLELKLNKLGADFYKTNRGGLITFHGPGQLVAYPIINLKHFTPSIKWFVQSIEQT----- 119
E ++ G T+RGG IT+HGPGQLV YPII L + +V+ +E++
Sbjct: 63 THERPID--GTPVVDTDRGGKITWHGPGQLVGYPIIGLAEPLDVVN-YVRRLEESLIQVC 119
Query: 120 QEFSLNAGLIPKYTGVFLDDE--YKVCAIGVHSSLYITHHGLAINCDTDLTWFNHITPCG 177
+ L+AG + +GV+L KV AIGV S T HG A+NCD DL F I PCG
Sbjct: 120 ADLGLHAGRVDGRSGVWLPGRPARKVAAIGVRVSRATTLHGFALNCDCDLAAFTAIVPCG 179
Query: 178 IKDKQVTSLSKHLSKDITVD 197
I D VTSLS L + +TVD
Sbjct: 180 ISDAAVTSLSAELGRTVTVD 199
>pdb|2QHT|A Chain A, Structural Basis Of Octanoic Acid Recognition By
Lipoate-Protein Ligase B
pdb|2QHU|A Chain A, Structural Basis Of Octanoic Acid Recognition By
Lipoate-Protein Ligase B
pdb|2QHV|A Chain A, Structural Basis Of Octanoic Acid Recognition By
Lipoate-protein Ligase B
Length = 210
Score = 113 bits (282), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 10 LGLVSYSNGIKIQEHYVNKLKTLISKPSNHSGTLLLLEHKPVYTIGIRSLKEYDENLELK 69
LGLV Y Q+ ++ N TLLLLEH V T+G ++ E E
Sbjct: 8 LGLVPYGEAWAYQKRVHREVVA-----GNRPPTLLLLEHPRVITLGRKATGENLLFPESW 62
Query: 70 LNKLGADFYKTNRGGLITFHGPGQLVAYPIINLKHFTPSIKWFVQSIEQT-----QEFSL 124
+ G + Y RGG +T+HGPGQLV YPI + ++ F++ IE+ + +
Sbjct: 63 YRENGFELYWVERGGDVTYHGPGQLVGYPIFPVGR---EVRRFLRQIEEAIVRVAAGYGI 119
Query: 125 NAGLIPKYTGVFLDDEYKVCAIGVHSSLYITHHGLAINCDTDLTWFNHITPCGIKDKQVT 184
+A P Y GV++ ++ K+CAIGV ++ HG A+N +TDL F I PCG+K K VT
Sbjct: 120 SAYPTPGYAGVWVGED-KLCAIGVAVKEGVSFHGFALNVNTDLNDFTVIVPCGLKGKGVT 178
Query: 185 SLSKHLSKDITVD 197
SL K L + + ++
Sbjct: 179 SLEKLLGRKVPME 191
>pdb|2QHS|A Chain A, Structural Basis Of Octanoic Acid Recognition By
Lipoate-protein Ligase B
Length = 237
Score = 112 bits (281), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 10 LGLVSYSNGIKIQEHYVNKLKTLISKPSNHSGTLLLLEHKPVYTIGIRSLKEYDENLELK 69
LGLV Y Q+ ++ N TLLLLEH V T+G ++ E E
Sbjct: 28 LGLVPYGEAWAYQKRVHREVVA-----GNRPPTLLLLEHPRVITLGRKATGENLLFPESW 82
Query: 70 LNKLGADFYKTNRGGLITFHGPGQLVAYPIINLKHFTPSIKWFVQSIEQT-----QEFSL 124
+ G + Y RGG +T+HGPGQLV YPI + ++ F++ IE+ + +
Sbjct: 83 YRENGFELYWVERGGDVTYHGPGQLVGYPIFPVGR---EVRRFLRQIEEAIVRVAAGYGI 139
Query: 125 NAGLIPKYTGVFLDDEYKVCAIGVHSSLYITHHGLAINCDTDLTWFNHITPCGIKDKQVT 184
+A P Y GV++ ++ K+CAIGV ++ HG A+N +TDL F I PCG+K K VT
Sbjct: 140 SAYPTPGYAGVWVGED-KLCAIGVAVKEGVSFHGFALNVNTDLNDFTVIVPCGLKGKGVT 198
Query: 185 SLSKHLSKDITVD 197
SL K L + + ++
Sbjct: 199 SLEKLLGRKVPME 211
>pdb|2VV4|B Chain B, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 32.0 bits (71), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 41 TDKSPFVIYDMQSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 100
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 101 SIPGFVNLDLNDQVTLLKYGVHEIIY 126
>pdb|3OSI|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSI|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrachloro-Bisphenol A (Tcbpa)
pdb|3OSW|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
pdb|3OSW|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tetrabromo-Bisphenol A (Tbbpa)
Length = 285
Score = 32.0 bits (71), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 51 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 110
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 111 SIPGFVNLDLNDQVTLLKYGVHEIIY 136
>pdb|2ZVT|A Chain A, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZVT|B Chain B, Cys285ser Mutant Ppargamma Ligand-Binding Domain Complexed
With 15-Deoxy-Delta12,14-Prostaglandin J2
Length = 286
Score = 32.0 bits (71), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 52 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGSQFRSVEAVQEITEYAK 111
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 112 SIPGFVNLDLNDQVTLLKYGVHEIIY 137
>pdb|3PBA|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PBA|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Monosulfate Tetrabromo-Bisphenol A
(Monotbbpa)
pdb|3PO9|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
pdb|3PO9|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain In
Complex With Tripropyltin
Length = 286
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 51 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 110
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 111 SIPGFVNLDLNDQVTLLKYGVHEIIY 136
>pdb|3U9Q|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With Decanoic
Acid And Pgc-1a Peptide
Length = 269
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 35 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 94
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 95 SIPGFVNLDLNDQVTLLKYGVHEIIY 120
>pdb|3ADS|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADS|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin
pdb|3ADT|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADT|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Hydroxy-Indole Acetate
pdb|3ADU|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADU|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate
pdb|3ADV|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADV|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Serotonin
pdb|3ADW|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADW|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
5-Methoxy-Indole Acetate And 15-Oxo-Eicosatetraenoic
Acid
pdb|3ADX|A Chain A, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3ADX|B Chain B, Human Ppargamma Ligand-Binding Domain In Complex With
Indomethacin And Nitro-233
pdb|3R8I|A Chain A, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|3R8I|B Chain B, Crystal Structure Of Ppargamma With An Achiral
Ureidofibrate Derivative (Rt86)
pdb|2YFE|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|2YFE|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 1
pdb|4A4V|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4V|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|A Chain A, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4A4W|B Chain B, Ligand Binding Domain Of Human Ppar Gamma In Complex With
Amorfrutin 2
pdb|4E4K|A Chain A, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4K|B Chain B, Crystal Structure Of Ppargamma With The Ligand Jo21
pdb|4E4Q|A Chain A, Crystal Structure Of Ppargamma With The Ligand Fs214
pdb|4E4Q|B Chain B, Crystal Structure Of Ppargamma With The Ligand Fs214
Length = 287
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 52 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 111
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 112 SIPGFVNLDLNDQVTLLKYGVHEIIY 137
>pdb|3CWD|A Chain A, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
pdb|3CWD|B Chain B, Molecular Recognition Of Nitro-Fatty Acids By Ppar Gamma
Length = 270
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 35 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 94
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 95 SIPGFVNLDLNDQVTLLKYGVHEIIY 120
>pdb|2PRG|A Chain A, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2PRG|B Chain B, Ligand-Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2F4B|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2F4B|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With An Agonist
pdb|2FVJ|A Chain A, A Novel Anti-adipogenic Partial Agonist Of Peroxisome
Proliferator- Activated Receptor-gamma (pparg) Recruits
Pparg-coactivator-1 Alpha (pgc1a) But Potentiates
Insulin Signaling In Vitro
pdb|2G0G|A Chain A, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0G|B Chain B, Structure-based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-ray
Crystallography And In Vitro/in Vivo Biological
Activities
pdb|2G0H|A Chain A, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2G0H|B Chain B, Structure-Based Drug Design Of A Novel Family Of Ppar
Partial Agonists: Virtual Screening, X-Ray
Crystallography And In VitroIN VIVO BIOLOGICAL
ACTIVITIES
pdb|2ATH|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2ATH|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma Im Complex With An Agonist
pdb|2GTK|A Chain A, Structure-Based Design Of Indole Propionic Acids As Novel
Pparag Co-Agonists
pdb|2HWQ|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWQ|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|A Chain A, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2HWR|B Chain B, Structural Basis For The Structure-Activity Relationships
Of Peroxisome Proliferator-Activated Receptor Agonists
pdb|2Q8S|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|2Q8S|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
AGONIST
pdb|3G9E|A Chain A, Aleglitaar. A New. Potent, And Balanced Dual PparaG
AGONIST For The Treatment Of Type Ii Diabetes
pdb|3IA6|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3IA6|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Ppar GammaALPHA DUAL
Agonist
pdb|3FEJ|A Chain A, Design And Biological Evaluation Of Novel, Balanced Dual
PparaG AGONISTS
pdb|3GBK|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3GBK|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With A Potent And Selective Agonist
pdb|3NOA|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3NOA|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complex With A Potency Improved Agonist
pdb|3QT0|A Chain A, Revealing A Steroid Receptor Ligand As A Unique Ppargamma
Agonist
Length = 271
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 36 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 95
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 96 SIPGFVNLDLNDQVTLLKYGVHEIIY 121
>pdb|2Q59|A Chain A, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
Length = 274
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 39 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGXQFRSVEAVQEITEYAK 98
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 99 SIPGFVNLDLNDQVTLLKYGVHEIIY 124
>pdb|2I4J|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4J|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Agonist Lt160 (Ureidofibrate Derivative)
pdb|2I4P|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4P|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative).
Structure Obtained From Crystals Of The Apo-Form Soaked
For 30 Days.
pdb|2I4Z|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|2I4Z|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Partial Agonist Lt127 (Ureidofibrate Derivative). This
Structure Has Been Obtained From Crystals Soaked For 6
Hours.
pdb|3B3K|A Chain A, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3B3K|B Chain B, Crystal Structure Of The Complex Between Ppargamma And The
Full Agonist Lt175
pdb|3CDS|A Chain A, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3CDS|B Chain B, Crystal Structure Of The Complex Between Ppar-Gamma And
The Agonist Lt248 (Clofibric Acid Analogue)
pdb|3D6D|A Chain A, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3D6D|B Chain B, Crystal Structure Of The Complex Between Ppargamma Lbd And
The Lt175(R-Enantiomer)
pdb|3CDP|A Chain A, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|3CDP|B Chain B, Crystal Structure Of Ppar-Gamma Lbd Complexed With A
Partial Agonist, Analogue Of Clofibric Acid
pdb|2ZK0|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK0|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain
pdb|2ZK1|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK1|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With
15-Deoxy-Delta12,14- Prostaglandin J2
pdb|2ZK2|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK2|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Glutathion
Conjugated 15-Deoxy-Delta12,14-Prostaglandin J2
pdb|2ZK3|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK3|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 8-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK4|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With 15-Oxo-
Eicosatetraenoic Acid
pdb|2ZK5|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK5|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With Nitro-233
pdb|2ZK6|A Chain A, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZK6|B Chain B, Human Peroxisome Proliferator-Activated Receptor Gamma
Ligand Binding Domain Complexed With C8-Bodipy
pdb|2ZNO|A Chain A, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|2ZNO|B Chain B, Human Pprr Gamma Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp703
pdb|3HO0|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HO0|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3HOD|B Chain B, Crystal Structure Of The Ppargamma-Lbd Complexed With A
New Aryloxy-3phenylpropanoic Acid
pdb|3AN3|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN3|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo3s
pdb|3AN4|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3AN4|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With A
Gamma Selective Agonist Mo4r
pdb|3VJH|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJH|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl35
pdb|3VJI|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
pdb|3VJI|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Jkpl53
Length = 286
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 52 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 111
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 112 SIPGFVNLDLNDQVTLLKYGVHEIIY 137
>pdb|1NYX|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
pdb|1NYX|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With An Agonist
Length = 276
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 41 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 100
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 101 SIPGFVNLDLNDQVTLLKYGVHEIIY 126
>pdb|1RDT|D Chain D, Crystal Structure Of A New Rexinoid Bound To The Rxralpha
Ligand Binding Doamin In The RxralphaPPARGAMMA
HETERODIMER
Length = 284
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 49 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 108
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 109 SIPGFVNLDLNDQVTLLKYGVHEIIY 134
>pdb|3VN2|A Chain A, Crystal Structure Of Ppargamma Complexed With Telmisartan
Length = 285
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 50 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 109
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 110 SIPGFVNLDLNDQVTLLKYGVHEIIY 135
>pdb|3B0Q|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0Q|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Mcc555
pdb|3B0R|A Chain A, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
pdb|3B0R|B Chain B, Human Ppar Gamma Ligand Binding Dmain Complexed With
Gw9662 In A Covalent Bonded Form
Length = 274
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 40 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 99
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 100 SIPGFVNLDLNDQVTLLKYGVHEIIY 125
>pdb|4PRG|A Chain A, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|B Chain B, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|C Chain C, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|4PRG|D Chain D, 0072 Partial Agonist Ppar Gamma Cocrystal
pdb|1PRG|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|1PRG|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma
pdb|2QMV|A Chain A, High Resolution Structure Of Peroxisone
Proliferation-Activated Receptor Gamma And
Characterisation Of Its Interaction With The Co-
Activator Transcriptional Intermediary Factor 2
Length = 270
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 36 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 95
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 96 SIPGFVNLDLNDQVTLLKYGVHEIIY 121
>pdb|1KNU|A Chain A, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|1KNU|B Chain B, Ligand Binding Domain Of The Human Peroxisome Proliferator
Activated Receptor Gamma In Complex With A Synthetic
Agonist
pdb|2XKW|A Chain A, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|2XKW|B Chain B, Ligand Binding Domain Of Human Ppar-Gamma In Complex With
The Agonist Pioglitazone
pdb|3R5N|A Chain A, Crystal Structure Of Ppargammalbd Complexed With The
Agonist Magnolol
Length = 274
Score = 31.6 bits (70), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 39 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 98
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 99 SIPGFVNLDLNDQVTLLKYGVHEIIY 124
>pdb|1WM0|X Chain X, Ppargamma In Complex With A 2-Baba Compound
Length = 292
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 57 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 116
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 117 SIPGFVNLDLNDQVTLLKYGVHEIIY 142
>pdb|2OM9|A Chain A, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|B Chain B, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|C Chain C, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|2OM9|D Chain D, Ajulemic Acid, A Synthetic Cannabinoid Bound To Ppar Gamma
pdb|3SZ1|A Chain A, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
pdb|3SZ1|B Chain B, Human Ppar Gamma Ligand Binding Domain In Complex With
Luteolin And Myristic Acid
Length = 278
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 43 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 102
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 103 SIPGFVNLDLNDQVTLLKYGVHEIIY 128
>pdb|1FM6|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM6|X Chain X, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Rosiglitazone And Co-Activator Peptides.
pdb|1FM9|D Chain D, The 2.1 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Rxralpha And Ppargamma Ligand
Binding Domains Respectively Bound With 9-Cis Retinoic
Acid And Gi262570 And Co-Activator Peptides.
pdb|1ZGY|A Chain A, Structural And Biochemical Basis For Selective Repression
Of The Orphan Nuclear Receptor Lrh-1 By Shp
pdb|2POB|A Chain A, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|2POB|B Chain B, Ppargamma Ligand Binding Domain Complexed With A
Farglitazar Analogue Gw4709
pdb|3FUR|A Chain A, Crystal Structure Of Pparg In Complex With Int131
pdb|3H0A|D Chain D, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Gamma (Pparg) And Retinoic Acid Receptor Alpha
(Rxra) In Complex With 9-Cis Retinoic Acid, Co-Activator
Peptide, And A Partial Agonist
pdb|3K8S|A Chain A, Crystal Structure Of Pparg In Complex With T2384
pdb|3K8S|B Chain B, Crystal Structure Of Pparg In Complex With T2384
pdb|3KMG|A Chain A, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
pdb|3KMG|D Chain D, The X-Ray Crystal Structure Of Ppar-Gamma In Complex With
An Indole Derivative Modulator, Gsk538, And An Src-1
Peptide
Length = 272
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 37 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 96
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 97 SIPGFVNLDLNDQVTLLKYGVHEIIY 122
>pdb|1I7I|A Chain A, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
pdb|1I7I|B Chain B, Crystal Structure Of The Ligand Binding Domain Of Human
Ppar-Gamma In Complex With The Agonist Az 242
Length = 292
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 57 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 116
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 117 SIPGFVNLDLNDQVTLLKYGVHEIIY 142
>pdb|3PRG|A Chain A, Ligand Binding Domain Of Human Peroxisome Proliferator
Activated Receptor
Length = 278
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 43 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 102
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 103 SIPGFVNLDLNDQVTLLKYGVHEIIY 128
>pdb|3T03|A Chain A, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
pdb|3T03|B Chain B, Crystal Structure Of Ppar Gamma Ligand Binding Domain In
Complex With A Novel Partial Agonist Gq-16
Length = 284
Score = 31.6 bits (70), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 49 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 108
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 109 SIPGFVNLDLNDQVTLLKYGVHEIIY 134
>pdb|2Q59|B Chain B, Crystal Structure Of Ppargamma Lbd Bound To Full Agonist
Mrl20
pdb|2Q5P|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5P|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Mrl24
pdb|2Q5S|A Chain A, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q5S|B Chain B, Crystal Structure Of Ppargamma Bound To Partial Agonist
Ntzdpa
pdb|2Q61|A Chain A, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q61|B Chain B, Crystal Structure Of Ppargamma Ligand Binding Domain Bound
To Partial Agonist Sr145
pdb|2Q6R|A Chain A, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6R|B Chain B, Crystal Structure Of Ppar Gamma Complexed With Partial
Agonist Sf147
pdb|2Q6S|A Chain A, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
pdb|2Q6S|B Chain B, 2.4 Angstrom Crystal Structure Of Ppar Gamma Complexed To
Bvt.13 Without Co-Activator Peptides
Length = 274
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 39 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 98
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 99 SIPGFVNLDLNDQVTLLKYGVHEIIY 124
>pdb|3R8A|A Chain A, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
pdb|3R8A|B Chain B, X-Ray Crystal Structure Of The Nuclear Hormone Receptor
Ppar-Gamma In A Complex With A Compound With Dual Ppar
Gamma Agonism And Angiotensin Ii Type I Receptor
Antagonism Activity
Length = 282
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 47 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 106
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 107 SIPGFVNLDLNDQVTLLKYGVHEIIY 132
>pdb|3S9S|A Chain A, Ligand Binding Domain Of Ppargamma Complexed With A
Benzimidazole Partial Agonist
Length = 284
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 49 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 108
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 109 SIPGFVNLDLNDQVTLLKYGVHEIIY 134
>pdb|2HFP|A Chain A, Crystal Structure Of Ppar Gamma With N-Sulfonyl-2-Indole
Carboxamide Ligands
Length = 282
Score = 31.6 bits (70), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 47 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 106
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 107 SIPGFVNLDLNDQVTLLKYGVHEIIY 132
>pdb|2VV1|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
Length = 276
Score = 31.6 bits (70), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 41 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 100
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 101 SIPGFVNLDLNDQVTLLKYGVHEIIY 126
>pdb|2VSR|A Chain A, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VSR|B Chain B, Hppargamma Ligand Binding Domain In Complex With
9-(S)-Hode
pdb|2VST|A Chain A, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VST|B Chain B, Hppargamma Ligand Binding Domain In Complex With 13-(S)-
Hode
pdb|2VV0|A Chain A, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV0|B Chain B, Hppargamma Ligand Binding Domain In Complex With Dha
pdb|2VV1|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Hdha
pdb|2VV2|A Chain A, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV2|B Chain B, Hppargamma Ligand Binding Domain In Complex With 5-Hepa
pdb|2VV3|A Chain A, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV3|B Chain B, Hppargamma Ligand Binding Domain In Complex With 4-Oxodha
pdb|2VV4|A Chain A, Hppargamma Ligand Binding Domain In Complex With 6-Oxoote
Length = 276
Score = 31.6 bits (70), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 41 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 100
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 101 SIPGFVNLDLNDQVTLLKYGVHEIIY 126
>pdb|1ZEO|A Chain A, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|1ZEO|B Chain B, Crystal Structure Of Human Ppar-Gamma Ligand Binding
Domain Complexed With An Alpha-Aryloxyphenylacetic Acid
Agonist
pdb|2P4Y|A Chain A, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|2P4Y|B Chain B, Crystal Structure Of Human Ppar-Gamma-Ligand Binding
Domain Complexed With An Indole-Based Modulator
pdb|3TY0|A Chain A, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
pdb|3TY0|B Chain B, Structure Of Ppargamma Ligand Binding Domain In Complex
With (R)-5-(3-
((3-(6-Methoxybenzo[d]isoxazol-3-Yl)-2-Oxo-2,
3-Dihydro-1h-
Benzo[d]imidazol-1-Yl)methyl)phenyl)-5-
Methyloxazolidine-2,4-Dione
Length = 277
Score = 31.6 bits (70), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 42 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 101
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 102 SIPGFVNLDLNDQVTLLKYGVHEIIY 127
>pdb|3ET3|A Chain A, Structure Of Ppargamma With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 292
Score = 31.6 bits (70), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 57 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 116
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 117 SIPGFVNLDLNDQVTLLKYGVHEIIY 142
>pdb|1K74|D Chain D, The 2.3 Angstrom Resolution Crystal Structure Of The
Heterodimer Of The Human Ppargamma And Rxralpha Ligand
Binding Domains Respectively Bound With Gw409544 And
9-Cis Retinoic Acid And Co-Activator Peptides
Length = 283
Score = 31.6 bits (70), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 48 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 107
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 108 SIPGFVNLDLNDQVTLLKYGVHEIIY 133
>pdb|3BC5|A Chain A, X-Ray Crystal Structure Of Human Ppar Gamma With
2-(5-(3-(2-
(5-Methyl-2-Phenyloxazol-4-Yl)ethoxy)benzyl)-2-Phenyl-
2h-1, 2,3-Triazol-4-Yl)acetic Acid
Length = 296
Score = 31.6 bits (70), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 61 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 120
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 121 SIPGFVNLDLNDQVTLLKYGVHEIIY 146
>pdb|3CS8|A Chain A, Structural And Biochemical Basis For The Binding
Selectivity Of Pparg To Pgc-1a
Length = 275
Score = 31.6 bits (70), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 41 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 100
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 101 SIPGFVNLDLNDQVTLLKYGVHEIIY 126
>pdb|3ET0|A Chain A, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
pdb|3ET0|B Chain B, Structure Of Ppargamma With 3-(5-Methoxy-1h-Indol-3-Yl)-
Propionic Acid
Length = 292
Score = 31.6 bits (70), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 57 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGXQFRSVEAVQEITEYAK 116
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 117 SIPGFVNLDLNDQVTLLKYGVHEIIY 142
>pdb|3LMP|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3B1M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator Cerco-A
pdb|3V9T|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9V|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|3V9Y|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
pdb|4F9M|A Chain A, Crystal Structure Of The Ppargamma-Lbd Complexed With A
Cercosporamide Derivative Modulator
Length = 283
Score = 31.6 bits (70), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 48 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 107
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 108 SIPGFVNLDLNDQVTLLKYGVHEIIY 133
>pdb|3DZU|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Bvt.13, 9-Cis Retinoic Acid And Ncoa2
Peptide
pdb|3DZY|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Rosiglitazone, 9-Cis Retinoic Acid And
Ncoa2 Peptide
pdb|3E00|D Chain D, Intact Ppar Gamma - Rxr Alpha Nuclear Receptor Complex On
Dna Bound With Gw9662, 9-Cis Retinoic Acid And Ncoa2
Peptide
Length = 419
Score = 31.2 bits (69), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 12/86 (13%)
Query: 80 TNRGGLITFHGPGQLVAYPIINLKHFTP--------SIKWF----VQSIEQTQEFSLNAG 127
T++ + + ++ I KH TP +I+ F +S+E QE + A
Sbjct: 184 TDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAK 243
Query: 128 LIPKYTGVFLDDEYKVCAIGVHSSLY 153
IP + + L+D+ + GVH +Y
Sbjct: 244 SIPGFVNLDLNDQVTLLKYGVHEIIY 269
>pdb|2B50|A Chain A, Human Nuclear Receptor-Ligand Complex 2
pdb|2B50|B Chain B, Human Nuclear Receptor-Ligand Complex 2
Length = 272
Score = 30.8 bits (68), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 85 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 123
>pdb|2XYJ|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYJ|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYW|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|A Chain A, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
pdb|2XYX|B Chain B, Novel Sulfonylthiadiazoles With An Unusual Binding Mode As
Partial Dual Peroxisome Proliferator-Activated Receptor
(Ppar) Gamma-Delta Agonists With High Potency And
In-Vivo Efficacy
Length = 288
Score = 30.4 bits (67), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 100 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 138
>pdb|2GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|2BAW|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2BAW|B Chain B, Human Nuclear Receptor-Ligand Complex 1
pdb|3D5F|A Chain A, Crystal Structure Of Ppar-Delta Complex
pdb|3D5F|B Chain B, Crystal Structure Of Ppar-Delta Complex
Length = 267
Score = 30.4 bits (67), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 79 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 117
>pdb|3SP9|A Chain A, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
pdb|3SP9|B Chain B, Structural Basis For Iloprost As A Dual PparalphaDELTA
AGONIST
Length = 281
Score = 30.4 bits (67), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 93 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 131
>pdb|3TKM|A Chain A, Crystal Structure Ppar Delta Binding Gw0742
Length = 275
Score = 30.4 bits (67), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 87 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 125
>pdb|2AWH|A Chain A, Human Nuclear Receptor-Ligand Complex 1
pdb|2AWH|B Chain B, Human Nuclear Receptor-Ligand Complex 1
Length = 268
Score = 30.4 bits (67), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 80 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 118
>pdb|2ZNP|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNP|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp204
pdb|2ZNQ|A Chain A, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
pdb|2ZNQ|B Chain B, Human Pprr Delta Ligand Binding Domain In Complex With A
Synthetic Agonist Tipp401
Length = 276
Score = 30.4 bits (67), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 88 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 126
>pdb|1Y0S|A Chain A, Crystal Structure Of Ppar Delta Complexed With Gw2331
pdb|1Y0S|B Chain B, Crystal Structure Of Ppar Delta Complexed With Gw2331
Length = 272
Score = 30.4 bits (67), Expect = 0.79, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 84 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 122
>pdb|1GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|1GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-Activated Receptors
pdb|3GWX|A Chain A, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3GWX|B Chain B, Molecular Recognition Of Fatty Acids By Peroxisome
Proliferator-activated Receptors
pdb|3DY6|A Chain A, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3DY6|B Chain B, Ppardelta Complexed With An Anthranilic Acid Partial
Agonist
pdb|3PEQ|A Chain A, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
pdb|3PEQ|B Chain B, Ppard Complexed With A Phenoxyacetic Acid Partial Agonist
Length = 271
Score = 30.4 bits (67), Expect = 0.79, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 83 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 121
>pdb|2Q5G|A Chain A, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
pdb|2Q5G|B Chain B, Ligand Binding Domain Of Ppar Delta Receptor In Complex
With A Partial Agonist
Length = 283
Score = 30.4 bits (67), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 95 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 133
>pdb|3ET2|A Chain A, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
pdb|3ET2|B Chain B, Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy-
Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid
Length = 287
Score = 30.4 bits (67), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 99 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 137
>pdb|2J14|A Chain A, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|2J14|B Chain B, 3,4,5-Trisubstituted Isoxazoles As Novel Ppardelta
Agonists: Part2
pdb|3OZ0|A Chain A, Ppar Delta In Complex With Azppard02
Length = 285
Score = 30.4 bits (67), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 24/39 (61%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP ++ +FL+D+ + GVH +++
Sbjct: 97 TVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIF 135
>pdb|2J6J|A Chain A, Prefusion Form Of The Vesicular Stomatitis Virus
Glycoprotein G Ectodomain
Length = 422
Score = 29.6 bits (65), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 17/48 (35%), Positives = 29/48 (60%), Gaps = 5/48 (10%)
Query: 88 FHGPGQLVAYPIINLKHFTPSIKWFVQSIEQTQEFS-LNAGLIPKYTG 134
++GP Y +++ FTPS++ +SIEQT++ + LN G P+ G
Sbjct: 72 WYGP----KYITQSIRSFTPSVEQCKESIEQTKQGTWLNPGFPPQSCG 115
>pdb|2CMZ|A Chain A, Crystal Structure Of Vsv-Indiana (Mudd-Summers Strain)
Glycoprotein Under Its Acidic Conformation
pdb|2CMZ|B Chain B, Crystal Structure Of Vsv-Indiana (Mudd-Summers Strain)
Glycoprotein Under Its Acidic Conformation
pdb|2CMZ|C Chain C, Crystal Structure Of Vsv-Indiana (Mudd-Summers Strain)
Glycoprotein Under Its Acidic Conformation
Length = 423
Score = 29.6 bits (65), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 17/48 (35%), Positives = 29/48 (60%), Gaps = 5/48 (10%)
Query: 88 FHGPGQLVAYPIINLKHFTPSIKWFVQSIEQTQEFS-LNAGLIPKYTG 134
++GP Y +++ FTPS++ +SIEQT++ + LN G P+ G
Sbjct: 72 WYGP----KYITQSIRSFTPSVEQCKESIEQTKQGTWLNPGFPPQSCG 115
>pdb|3GZ9|A Chain A, Crystal Structure Of Peroxisome Proliferator-Activated
Receptor Delta (Ppard) In Complex With A Full Agonist
Length = 269
Score = 29.3 bits (64), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 11/39 (28%), Positives = 23/39 (58%)
Query: 115 SIEQTQEFSLNAGLIPKYTGVFLDDEYKVCAIGVHSSLY 153
++E +E + A IP + +FL+D+ + GVH +++
Sbjct: 83 TVETVRELTEFAKSIPSFGSLFLNDQVTLLKYGVHEAIF 121
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.138 0.412
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,568,429
Number of Sequences: 62578
Number of extensions: 270451
Number of successful extensions: 1054
Number of sequences better than 100.0: 56
Number of HSP's better than 100.0 without gapping: 54
Number of HSP's successfully gapped in prelim test: 2
Number of HSP's that attempted gapping in prelim test: 994
Number of HSP's gapped (non-prelim): 56
length of query: 229
length of database: 14,973,337
effective HSP length: 95
effective length of query: 134
effective length of database: 9,028,427
effective search space: 1209809218
effective search space used: 1209809218
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 50 (23.9 bits)